Gam S. Zamil

FDA investigator · also recorded as Fae Gam Zamil

Appears on 18 documents from 2016 to 2024, mostly at sites in New York. Most often cites stability testing (21 CFR 211.166).

18
Documents on file
3.4
Observations per 483
2016
First seen
2024
Most recent

What they cite most

From 61 observations

Activity by year

2016: 1, 2017: 1, 2018: 1, 2019: 3, 2020: 1, 2021: 2, 2022: 3, 2023: 3, 2024: 3

Where

New York 10 · India 5 · Bangladesh 1 · California 1 · Canada 1

Is Gam S. Zamil coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

18 documents, newest first
FirmOpen
483 Vitane Pharmaceutical, IncOct 23, 2024 · Congers, New York
483 Advanced Pharmaceutical Technology, Inc.Aug 1, 2024 · Elmsford, New York
483 Advanced Pharmaceutical Technology IncAug 1, 2024 · Elmsford, New York
483 Spirit PharmaceuticalsNov 1, 2023 · Ronkonkoma, New York
483 Sciarra Laboratories, IncAug 7, 2023 · Hicksville, New York
483 ACI HealthCare LimitedApr 6, 2023 · Narayanganj, Bangladesh
483 LNK International, Inc.Dec 13, 2022 · Hauppauge, New York

About this profile

What does Gam S. Zamil inspect?

Gam S. Zamil appears on 18 documents on file covering 14 sites, mostly in New York.

What do they cite most often?

21 CFR 211.166 (stability testing), followed by 21 CFR 211.100 and 21 CFR 211.142.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Gam S. Zamil is dated Oct 23, 2024.